Static Chart Monte Rosa Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 04:00:00 2026-11-13 pm EST			5-day change	1st Jan Change
9.370 ^USD	+0.64%		-11.35%	-40.24%

Nov. 09	Monte Rosa Therapeutics Presents Preclinical Data On MRT-8102 In Gout	CI
Nov. 05	Monte Rosa Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI

Duration

Period